Melagatran structure
|
Common Name | Melagatran | ||
---|---|---|---|---|
CAS Number | 159776-70-2 | Molecular Weight | 429.51300 | |
Density | 1.41g/cm3 | Boiling Point | N/A | |
Molecular Formula | C22H31N5O4 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of MelagatranMelagatran is a direct and oral active inhibitor of thrombin, without interacting with any other enzymes in the coagulation cascade or fibrinolytic enzymes aside from thrombin. Melagatran does not require endogenous co-factors for its antithrombin effect and may help to alleviate some of the damaging effects of endotoxemia[1]. Melagatran has the potential to provide a rational approach in the prevention of arterial occlusion[2]. |
Name | melagatran |
---|---|
Synonym | More Synonyms |
Description | Melagatran is a direct and oral active inhibitor of thrombin, without interacting with any other enzymes in the coagulation cascade or fibrinolytic enzymes aside from thrombin. Melagatran does not require endogenous co-factors for its antithrombin effect and may help to alleviate some of the damaging effects of endotoxemia[1]. Melagatran has the potential to provide a rational approach in the prevention of arterial occlusion[2]. |
---|---|
Related Catalog | |
Target |
Thrombin[1] |
References |
Density | 1.41g/cm3 |
---|---|
Molecular Formula | C22H31N5O4 |
Molecular Weight | 429.51300 |
Exact Mass | 429.23800 |
PSA | 148.61000 |
LogP | 2.33060 |
Index of Refraction | 1.67 |
2-[[(1R)-2-[(2S)-2-[(4-carbamimidoylphenyl)methylcarbamoyl]azetidin-1-yl]-1-cyclohexyl-2-oxoethyl]amino]acetic acid |